Skip to main content

Supreme Court extends pause on abortion pill restrictions through Thursday

16 sources|Diversity: 93%|

Left(8)

NPRAMay 11, 9:14 PM

Abortion pill by mail allowed for at least 3 more days, the Supreme Court says

Full access to the abortion pill mifepristone, including through telemedicine and the mail, will continue for at least three more days, the high court said on Monday.

LA TimesAMay 7, 10:39 PM

Louisiana urges Supreme Court to block abortion pills sent by mail

The justices are likely to act soon on emergency appeals filed by two makers of mifepristone, used in abortions.

LA TimesAMay 9, 10:00 AM

California abortion pill suppliers ready with workaround in case of Supreme Court ban

The U.S. Supreme Court is weighing whether to restrict access to the country's most popular abortion method, but California's network of online providers and pharmaceutical suppliers already has an al

The GuardianAMay 11, 8:06 PM

US supreme court temporarily extends access to mail-order abortion medication mifepristone

Louisiana had sued the FDA last fall, arguing that prescribing mifepristone interfered with state’s ban on abortion Sign up for the Breaking News US newsletter email The US supreme court extended a

MSNBCCMay 11, 8:11 PM

Supreme Court maintains mail access to abortion pill mifepristone for now

Justice Alito previously issued orders temporarily keeping the drug available pending further review from the full court. He extended those orders through Thursday. The post Supreme Court maintains m

NBC NewsBMay 11, 10:57 PM

Supreme Court extends access to abortion pill by mail

Supreme Court extends access to abortion pill by mail

CBS NewsBMay 11, 7:54 PM

Supreme Court continues to temporarily maintain mail access to abortion pill

Justice Samuel Alito extended an administrative stay that maintained access to mifepristone through the mail.

New York TimesAMay 11, 8:03 PM

Supreme Court Continues Access to Abortion Pill by Mail, for a Few Days

Justice Samuel A. Alito Jr. has paused until at least Thursday a federal appeals court ruling against the Food and Drug Administration that would restrict access by mail to mifepristone.

Center(5)

Right(3)

Get this analysis in your inbox

The Daily Spectrum: one email, three perspectives on the day's biggest stories.

Free forever. Unsubscribe anytime. No spam.

Back to Compare